Jakob K. Reinhardt

Jakob K. Reinhardt

Auto-generated profile, based on publicly available information

Jakob K. Reinhardt

Division of Pharmaceutical Biology, University of Basel, Klingelbergstrasse 50, CH-4056, Basel, Switzerland

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2020 in Phytomedicine
Verified
Journal Article
Closed access
CGCarsten Gründemann
Carsten Gründemann
JRJakob K. Reinhardt
Jakob K. Reinhardt
ULUlrike Lindequist
Ulrike Lindequist

17 May 2022 in Molecules
Verified
Journal Article
Open access
PDF file
AZAmy Marisa Zimmermann-Klemd
Amy Marisa Zimmermann-Klemd
JRJakob K. Reinhardt
Jakob K. Reinhardt
MWMoritz Winker
Moritz Winker
CGCarsten Gründemann
Carsten Gründemann
Modern phytotherapy is part of today’s conventional evidence-based medicine and the use of phytopharmaceuticals in integrative oncology is becoming increasingly popular. Approximately 40% of users of such phytopharmaceuticals are tumour patients. The present review provides an overview of the most important plants and nature-based compounds used in integrative oncology and illustrates their pharmacological potential in preclinical and clinical settings. A selection of promising anti-tumour plants and ingredients was made on the basis of scientific evidence and therapeutic practical relevance and included Boswellia, gingko, ginseng, ginger, and curcumin. In addition to these nominees, there is a large number of other interesting plants and plant ingredients that can be considered for the treatment of cancer diseases or for the treatment of tumour or tumour therapy-associated symptoms. Side effects and interactions are included in the discussion. However, with the regular and intended use of phytopharmaceuticals, the occurrence of adverse side effects is rather rare. Overall, the use of defined phytopharmaceuticals is recommended in the context of a rational integrative oncology approach.

31 May 2022 in Journal of Natural Products
Verified
Journal Article
Closed access
THTanja Hell
Tanja Hell
Adriano RutzAdriano Rutz
Adriano Rutz
LDLara Dürr
Lara Dürr
MDMaciej Dobrzyński
Maciej Dobrzyński
JRJakob K. Reinhardt
Jakob K. Reinhardt
EGEliane Garo
Eliane Garo

1 December 2021 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
NSNova Syafni
Nova Syafni
SDSeema Devi
Seema Devi
AZAmy Marisa Zimmermann-Klemd
Amy Marisa Zimmermann-Klemd
JRJakob K. Reinhardt
Jakob K. Reinhardt
ODOmbeline Danton
Ombeline Danton
Matthias HamburgerMatthias Hamburger
Matthias Hamburger
Some plants used in Traditional Chinese Medicine serve as treatment for disease states where a suppression of the cellular immune response is desired. However, the compounds responsible for the immunosuppressant effects of these plants are not necessarily known. The immunosuppressant compounds in the roots of Scutellaria baicalensis, one of the most promising plants identified in a previous screening, were tracked by HPLC activity profiling and concomitant on-line spectroscopic analysis. Compounds were then isolated by preparative chromatography, and structures elucidated by spectroscopic methods. Twelve flavonoids (5-16) were identified from the active time windows, and structurally related flavones 2, 4, and 17, and flavanones 1 and 3 were isolated from adjacent fractions. All flavonoids possessed an unusual substitution pattern on the B-ring, with an absence of substituents at C-3 and C-4. Compounds 11, 13, 14, and 16 inhibited T-cell proliferation (IC50 values at 12.1-39 μM) at non-cytotoxic concentrations. The findings may support the use of S. baicalensis in disorders where a modulation of the cellular immune response is desirable.

1 March 2022 in Journal of Natural Products
Verified
Journal Article
Closed access
LDLara Dürr
Lara Dürr
THTanja Hell
Tanja Hell
MDMaciej Dobrzyński
Maciej Dobrzyński
AMAlberto Mattei
Alberto Mattei
AJAnika John
Anika John
EGEliane Garo
Eliane Garo

9 November 2022 in Journal of Natural Products
Verified
Journal Article
Closed access
LDLara Dürr
Lara Dürr
JRJakob K. Reinhardt
Jakob K. Reinhardt
MDMaciej Dobrzyński
Maciej Dobrzyński
THTanja Hell
Tanja Hell
Martin SmieškoMartin Smieško
Martin Smieško
EGEliane Garo
Eliane Garo